AEDIFICA (AED.BR) Stock Fundamental Analysis

Europe • Euronext Brussels • EBR:AED • BE0003851681

74.05 EUR
-0.45 (-0.6%)
Last: Feb 9, 2026, 12:24 PM
Fundamental Rating

4

AED gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. While AED is still in line with the averages on profitability rating, there are concerns on its financial health. AED is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year AED was profitable.
  • AED had a positive operating cash flow in the past year.
  • AED had positive earnings in each of the past 5 years.
  • AED had a positive operating cash flow in each of the past 5 years.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • AED has a Return On Assets (2.73%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 4.96%, AED perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
  • AED's Return On Invested Capital of 3.52% is in line compared to the rest of the industry. AED outperforms 57.14% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AED is in line with the industry average of 3.45%.
  • The last Return On Invested Capital (3.52%) for AED is above the 3 year average (3.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 49.82%, AED is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of AED has declined.
  • The Operating Margin of AED (77.70%) is better than 71.43% of its industry peers.
  • In the last couple of years the Operating Margin of AED has remained more or less at the same level.
  • AED's Gross Margin of 97.93% is amongst the best of the industry. AED outperforms 97.62% of its industry peers.
  • In the last couple of years the Gross Margin of AED has remained more or less at the same level.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AED is destroying value.
  • AED has about the same amout of shares outstanding than it did 1 year ago.
  • AED has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for AED is higher compared to a year ago.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.90, we must say that AED is in the distress zone and has some risk of bankruptcy.
  • AED has a Altman-Z score of 0.90. This is comparable to the rest of the industry: AED outperforms 54.76% of its industry peers.
  • AED has a debt to FCF ratio of 24.91. This is a negative value and a sign of low solvency as AED would need 24.91 years to pay back of all of its debts.
  • The Debt to FCF ratio of AED (24.91) is worse than 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.58 indicates that AED is somewhat dependend on debt financing.
  • AED has a Debt to Equity ratio of 0.58. This is in the better half of the industry: AED outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.9
ROIC/WACC0.56
WACC6.23%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • AED has a Current Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.35, AED is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • AED has a Quick Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AED has a Quick ratio of 0.35. This is comparable to the rest of the industry: AED outperforms 47.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 114.94% over the past year.
  • The Earnings Per Share has been decreasing by -7.20% on average over the past years.
  • Looking at the last year, AED shows a quite strong growth in Revenue. The Revenue has grown by 8.06% in the last year.
  • AED shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.35% yearly.
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.19% on average over the next years.
  • Based on estimates for the next years, AED will show a small growth in Revenue. The Revenue will grow by 5.12% on average per year.
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.46 indicates a correct valuation of AED.
  • AED's Price/Earnings ratio is in line with the industry average.
  • AED is valuated rather cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 14.09 indicates a correct valuation of AED.
  • Based on the Price/Forward Earnings ratio, AED is valued a bit more expensive than 64.29% of the companies in the same industry.
  • AED's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.77.
Industry RankSector Rank
PE 15.46
Fwd PE 14.09
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AED is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
  • Based on the Price/Free Cash Flow ratio, AED is valued a bit more expensive than 78.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 33.97
EV/EBITDA 21.86
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of AED may justify a higher PE ratio.
PEG (NY)3.71
PEG (5Y)N/A
EPS Next 2Y3.32%
EPS Next 3Y3.19%

3

5. Dividend

5.1 Amount

  • AED has a Yearly Dividend Yield of 3.78%.
  • AED's Dividend Yield is slightly below the industry average, which is at 5.29.
  • AED's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.78%

5.2 History

  • On average, the dividend of AED grows each year by 22.82%, which is quite nice.
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • AED pays out 105.58% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (2/9/2026, 12:24:55 PM)

74.05

-0.45 (-0.6%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-28
Earnings (Next)02-13
Inst Owners41.34%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap3.52B
Revenue(TTM)358.28M
Net Income(TTM)175.81M
Analysts81.11
Price Target80.37 (8.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.78%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.95%
PT rev (3m)7.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.62%
EPS NY rev (3m)0.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 15.46
Fwd PE 14.09
P/S 9.98
P/FCF 33.97
P/OCF 12.06
P/B 0.99
P/tB 1.02
EV/EBITDA 21.86
EPS(TTM)4.79
EY6.47%
EPS(NY)5.26
Fwd EY7.1%
FCF(TTM)2.18
FCFY2.94%
OCF(TTM)6.14
OCFY8.29%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)3.71
PEG (5Y)N/A
Graham Number89.66
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexgc growth 3Y6.29%
ROICexgc growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.9
F-Score7
WACC6.23%
ROIC/WACC0.56
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.51%
EBIT Next 3Y6.39%
EBIT Next 5YN/A
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%

AEDIFICA / AED.BR FAQ

What is the fundamental rating for AED stock?

ChartMill assigns a fundamental rating of 4 / 10 to AED.BR.


What is the valuation status of AEDIFICA (AED.BR) stock?

ChartMill assigns a valuation rating of 2 / 10 to AEDIFICA (AED.BR). This can be considered as Overvalued.


How profitable is AEDIFICA (AED.BR) stock?

AEDIFICA (AED.BR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AED stock?

The Price/Earnings (PE) ratio for AEDIFICA (AED.BR) is 15.46 and the Price/Book (PB) ratio is 0.99.


Can you provide the financial health for AED stock?

The financial health rating of AEDIFICA (AED.BR) is 2 / 10.